A Smoking Cessation Intervention During Pregnancy in Argentina and Uruguay

NCT ID: NCT01852617

Last Updated: 2015-01-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6858 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-10-31

Study Completion Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Argentina and Uruguay are among the countries with the highest proportion of pregnant women who smoke. The implementation of an effective smoking cessation intervention would have a significant impact on the health of mothers and children. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide. However, it is under used in Argentina and Uruguay. We will conduct a two-arm, parallel cluster randomized controlled trial of an implementation intervention in 20 prenatal clinics in Argentina and Uruguay. Our primary hypothesis is that the intervention is feasible in prenatal clinics in Argentina and Uruguay and will increase the frequency of women receiving tobacco use cessation counseling during pregnancy. Our secondary hypothesis is that the intervention will decrease the frequency of women who smoke by the end of their pregnancies. Prenatal clinics will be randomly allocated to either an intervention or a control group after a baseline data collection period. Midwife facilitators in the ten intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The ten clinics in the control group will continue with their standard in-service activities. A follow-up data collection will be conducted immediately after delivery. The intervention will be tailored by formative research to be readily applicable to local prenatal care services at busy maternity hospitals, as well as to be acceptable to local pregnant women and health providers. The study will be conducted in 48 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation Pregnancy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Smoking Cessation Pregnancy Implementation Knowledge translation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Implementation of intervention

Midwife facilitators in the intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide

Group Type EXPERIMENTAL

Training in smoking cessation counseling

Intervention Type BEHAVIORAL

Midwife facilitators in the intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide

No implementation of the intervention

Standard in-service activities

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Training in smoking cessation counseling

Midwife facilitators in the intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Not having a smoking cessation program based on the "5 A's" for pregnant women in place.
* An estimated frequency of women receiving the "5 A's" intervention below 20%
* Having midwives or nurse-midwives as part of the hospital or primary health center staff.
* Having signed a letter of intention to participate in the project.
* Having at least 400 new pregnant women per year.

Exclusion Criteria

* None
Minimum Eligible Age

12 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tulane University

OTHER

Sponsor Role collaborator

Centers for Disease Control and Prevention

FED

Sponsor Role collaborator

Institute for Clinical Effectiveness and Health Policy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ezequiel Garcia Elorrio

Chief of Administration

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fernando Althabe, MD

Role: PRINCIPAL_INVESTIGATOR

Institute for Clinical Effectiveness and Health Policy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Lucio Meléndez

Adrogué, Buenos Aires, Argentina

Site Status

Hospital Evita Pueblo

Berazategui, Buenos Aires, Argentina

Site Status

Hospital M.V de Martínez

General Pacheco, Buenos Aires, Argentina

Site Status

Hospital Narciso López

Lanús, Buenos Aires, Argentina

Site Status

Hospital Héroes de Malvinas

Merlo, Buenos Aires, Argentina

Site Status

Hospital Municipal Ostaciana B. de Lavignolle

Morón, Buenos Aires, Argentina

Site Status

Hospital Materno Infantil de San Isidro

San Isidro, Buenos Aires, Argentina

Site Status

Hospital Bocalandro

Tres de Febrero, Buenos Aires, Argentina

Site Status

Hospital Maternidad Santa Rosa

Vicente López, Buenos Aires, Argentina

Site Status

Hospital San Roque

Manuel B. Gonnet, La Plata, Argentina

Site Status

Centro de Salud Badano Repetto

Montevideo, Montevideo Department, Uruguay

Site Status

Centro de Salud Cerro

Montevideo, Montevideo Department, Uruguay

Site Status

Centro de Salud Misurraco

Montevideo, Montevideo Department, Uruguay

Site Status

Centro de Salud Saint Bois

Montevideo, Montevideo Department, Uruguay

Site Status

Centro Materno Infantil 1

Montevideo, Montevideo Department, Uruguay

Site Status

Centro Materno Infantil 2

Montevideo, Montevideo Department, Uruguay

Site Status

Centro Materno Infantil 3

Montevideo, Montevideo Department, Uruguay

Site Status

Centro Materno Infantil 4

Montevideo, Montevideo Department, Uruguay

Site Status

Centro Materno Infantil 5

Montevideo, Montevideo Department, Uruguay

Site Status

Centro Materno Infantil 6

Montevideo, Montevideo Department, Uruguay

Site Status

Hospital Canzani

Montevideo, Montevideo Department, Uruguay

Site Status

Hospital Pereira Rossell

Montevideo, Montevideo Department, Uruguay

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Argentina Uruguay

References

Explore related publications, articles, or registry entries linked to this study.

Althabe F, Aleman A, Mazzoni A, Berrueta M, Morello P, Colomar M, Ciganda A, Becu A, Gibbons L, Llambi L, Bittar Gonzalez MG, Tong VT, Farr SL, Smith RA, Dietz PM, Johnson C, Buekens P, Belizan JM. Tobacco cessation intervention for pregnant women in Argentina and Uruguay: study protocol. Reprod Health. 2013 Aug 26;10(1):44. doi: 10.1186/1742-4755-10-44.

Reference Type DERIVED
PMID: 23971512 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1U48DP001948-01

Identifier Type: NIH

Identifier Source: org_study_id

View Link